Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia Gravis

被引：1

作者：

Sinaei, Farnaz ^{[1
]}

Fatehi, Farzad ^{[1
]}

Gharan, Shahram Oveis ^{[1
,2
]}

Ehsan, Soroush ^{[1
]}

Kamali, Koorosh ^{[3
]}

Amirzargar, Aliakbar ^{[4
,5
]}

Mahmoudi, Mahdi ^{[6
]}

Vaghefifar, Alaleh ^{[1
]}

Nafissi, Shahriar ^{[1
]}

机构：

[1] Univ Tehran Med Sci, Shariati Hosp, Dept Neurol, Tehran, Iran

[2] Rush Univ, Med Ctr, Rush Alzheimer Dis Ctr, Chicago, IL 60612 USA

[3] Zanjan Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Zanjan, Iran

[4] Univ Tehran Med Sci, Mol Immunol Res Ctr, Sch Med, Tehran, Iran

[5] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran

[6] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr RRC, Tehran, Iran

来源：

JOURNAL OF NEUROMUSCULAR DISEASES | 2021年 / 8卷 / 05期

关键词：

Myasthenia gravis; treatment; severity; HLA class II;

D O I：

10.3233/JND-210700

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Myasthenia gravis is an autoimmune neuromuscular disease with a multifactorial etiology. A major part of the genetic susceptibility belongs to theHLAencoding genes. In this study, we investigated the role ofHLAclass II polymorphism in disease severity, and treatment response. In our 146 patients, 15 DRB1, 7DQA1, and 9DQB1 alleles, and 19 haplotypes were found. Adjusted p-values did not show any significant associations between these loci, disease severity and treatment outcome. Further studies in different populations with a larger number of patients are needed to determine the exact contribution of HLA class II alleles to MG prognosis.

引用

页码：827 / 829

页数：3

共 50 条

[21] HLA class I (A, B) and class II (DRB) association in Iranian myeloid leukemia patients
Amirzargar, AA
Khosravi, F
Sarrafnejad, A
TISSUE ANTIGENS, 2002, 59 : 71 - 71
[22] DISTRIBUTION OF HLA CLASS II ALLELES AND HAPLOTYPES IN A GROUP OF CELIAC DISEASE PATIENTS
Lazidou, Panagiota
Fotoulaki, Maria
Fleva, Alexandra
Giannakou, Anastasia
Mpantadaki, Maria
Stasinou, Eleanna
Emporiadou, Maria
Pavlitou-Tsiontsi, Aikaterini
HLA, 2016, 87 (04) : 310 - 310
[23] Lack of association of HLA class II alleles with peanut allergy
Shreffler, Wayne G.
Charlop-Powers, Zachary
Sicherer, Scott H.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 96 (06) : 865 - 869
[24] Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population
Tastan, HB
Akar, A
Orkunoglu, FE
Arca, E
Inal, A
PIGMENT CELL RESEARCH, 2004, 17 (02): : 181 - 184
[25] Significant associations of HLA-B*51 and HLA-CW*06 alleles, and lack of association of Class II alleles with Behcets Disease in Saudi patients
Al Dalaan, A
Al Hussein, K
Al Shaikh, A
Al Saleh, S
Rama, NR
RHEUMATOLOGY, 2005, 44 : I89 - I89
[26] HLA class II alleles in patients with alopecia areata
Akar, A
Orkunoglu, E
Sengül, A
Ozata, M
Gür, AR
EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (03) : 236 - 239
[27] Binding of peptides of the human acetylcholine receptor alpha-subunit to HLA class II of patients with Myasthenia gravis
Zisman, E
Brautbar, C
Sela, M
Abramsky, O
Battat, S
Kirshner, SL
KatzLevy, Y
Dayan, M
Mozes, E
HUMAN IMMUNOLOGY, 1995, 44 (03) : 121 - 130
[28] How subtle differences in MHC class II affect the severity of experimental myasthenia gravis
Yang, BZ
McIntosh, KR
Drachman, DB
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 86 (01): : 45 - 58
[29] Association of HLA-DQA1*0101/2 and DQB1*0502 with Myasthenia Gravis in Southern Iranian Patients
Yousefipour, Gholam-Ali
Salami, Zahra
Farjadian, Shirin
IRANIAN JOURNAL OF IMMUNOLOGY, 2009, 6 (02) : 99 - 102
[30] HLA CLASS II ALLELES INFLUENCE RHEUMATOID ARTHRITIS SUSCEPTIBILITY, DISEASE PHENOTYPE AND RESPONSE TO TREATMENT IN SOUTH INDIAN TAMILS
Tamouza, Ryad
Mariaselvam, Christina Mary
Fortier, Catherine
Charron, Dominique
Krishnamoorthy, Rajagopal
Negi, Vir Singh
Tamouza, Ryad
TISSUE ANTIGENS, 2015, 85 (05): : 338 - 339

← 1 2 3 4 5 →